Posted on 5 May 2020
The team - led by Professor Peter O’Brien from the Department of Chemistry - made the discovery as part of their research programme synthesising 3-dimensional molecular ‘fragments’ for use in drug discovery.
Therapeutics
More than 100 of the research programme’s ‘fragments’ are part of a national library which was recently screened by a scientific team trying to find starting points to develop therapeutics in the fight against the current COVID -19 outbreak.
The team of researchers, working at UK’s national synchrotron science facility, were able to identify around 60 compounds that could bind to a key protein in the COVID 19 virus. Two of the fragments were synthesised by PhD students, Tom Downes and Paul Jones, in Professor O’Brien’s research team.
Emerge
Professor O’Brien said “It was great to see our 3-dimensional fragments turn up as hits in this screen, not least as this is the culmination of several years of synthetic work.
“It was especially exciting given their potential to ultimately generate new therapeutics targeting COVID-19 or other Coronaviruses that may emerge in the future.”
Fragment
The fragment, together with the other bound fragments from the screen, could provide a starting point for the development of better binding compounds by applying the techniques of fragment-based drug discovery. This would be the next step in the development of potential therapeutics.
Wednesday 23 October 2024
Wednesday 23 October 2024
Sunday 20 October 2024
Thursday 17 October 2024
Wednesday 16 October 2024
Our response to the coronavirus pandemic
We're working with partners in York and further afield as part of a global effort to fight the COVID-19 virus. From covid analysis in the labs to producing face shields for the frontline, we're using our knowledge and expertise to support the effort.